HOPPS Proposal Would Cut CT, MRI Reimbursement
CMS’s proposed hospital outpatient payments for 2014 would cut reimbursement for CT and MRI studies by 18 percent to 38 percent, according to the ACR.
CMS’s proposed hospital outpatient payments for 2014 would cut reimbursement for CT and MRI studies by 18 percent to 38 percent, according to an ACR analysis.
Under the proposed rule for 2014 changes to the Medicare’s Hospital Outpatient Prospective Payment System (HOPPS), CMS is proposing to use fiscal year 2011 cost data to establish cost centers for CT and MRI. These would be separate from the diagnostic radiology cost center for determining payments for CT and MRI in the inpatient setting, ACR said. This would result in drastic cuts to outpatient payments, and technical payments would fall below the rates in the Physician Fee Schedule, which would set the in-office imaging rates.
The ACR has been meeting with the federal Office of Management and Budget about this issue, requesting it not be included in the HOPPS rule. “However,” the ACR stated, “CMS has chosen to move forward and propose these changes.”
The proposed rule, released July 8, has a 60-day comment period.
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
March 26th 2025In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Study Explores Impact of Insurance on Treatment and Referrals for Patients with Uterine Fibroids
February 19th 2025Women with uterine fibroids and Medicaid coverage are significantly more likely to be treated with uterine artery embolization than those with commercial insurance, according to newly published research.
